PD-1 Refractory Advanced Melanoma
1 clinical trials · Condition
◉ Watch PD-1 Refractory Advanced Melanoma
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab/Lenvatinib With and Without Healthy Donor FMT (hdFMT) in Relapsed/ Refractory (R/R) Melanoma (NCT06030037) | Diwakar Davar | 2025-03-11 |
Track PD-1 Refractory Advanced Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.